| 产品详情 |
| Edit |   |
|---|
| Product Name | West Nile Virus Envelope protein, Strain NY99, Recombinant, aa291-692, His-Tag |
|---|
| Description | Purity ~95% (SDS-PAGE). Since the first human West Nile Virus (WNV) infection was identified in 1937 the virus has continued to spread. West Nile virus is now found in many regions of the world including Africa, Europe, West Asia, North and South America. WNV infection is asymptomatic in 80% of cases but some individuals develop severe West Nile fever. The symptoms of West Nile fever include fever, headache, nausea and vomiting. The virus has also been associated with neurological complications and fatalities in less than 1% of infected individuals. Currently, there is no licensed prophylactic vaccine or specific therapeutic treatment for West Nile virus infection in humans. Prevention of WNV infection is through vector control measures and the use of protective clothing to reduce human-to-human transmission. The major envelope glycoprotein, E, of WNV mediates viral attachment and entry by membrane fusion. The West Nile Virus Envelope protein has three domains I, II and III. Neutralizing West Nile virus-speci |
|---|
| Size | 100ug |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 397650 |
|---|
| Price | |
|---|
| Order / More Info | West Nile Virus Envelope protein, Strain NY99, Recombinant, aa291-692, His-Tag from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|